Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus

Epoxyeicosatrienoic acids (EETs) are derived from arachidonic acid and metabolized by soluble epoxide hydrolase (sEH). The role of EETs in synaptic function in the central nervous system is still largely unknown. We found that pharmacological inhibition of sEH to stabilize endogenous EETs and exogen...

Full description

Saved in:
Bibliographic Details
Main Authors: Han-Fang Wu, Yi-Ju Chen, Su-Zhen Wu, Chi-Wei Lee, I-Tuan Chen, Yi-Chao Lee, Chi-Chen Huang, Chung-Hsi Hsing, Chih-Wei Tang, Hui-Ching Lin
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2017/3467805
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550735244427264
author Han-Fang Wu
Yi-Ju Chen
Su-Zhen Wu
Chi-Wei Lee
I-Tuan Chen
Yi-Chao Lee
Chi-Chen Huang
Chung-Hsi Hsing
Chih-Wei Tang
Hui-Ching Lin
author_facet Han-Fang Wu
Yi-Ju Chen
Su-Zhen Wu
Chi-Wei Lee
I-Tuan Chen
Yi-Chao Lee
Chi-Chen Huang
Chung-Hsi Hsing
Chih-Wei Tang
Hui-Ching Lin
author_sort Han-Fang Wu
collection DOAJ
description Epoxyeicosatrienoic acids (EETs) are derived from arachidonic acid and metabolized by soluble epoxide hydrolase (sEH). The role of EETs in synaptic function in the central nervous system is still largely unknown. We found that pharmacological inhibition of sEH to stabilize endogenous EETs and exogenous 14,15-EET significantly increased the field excitatory postsynaptic potential (fEPSP) response in the CA1 area of the hippocampus, while additionally enhancing high-frequency stimulation- (HFS-) induced long-term potentiation (LTP) and forskolin- (FSK-) induced LTP. sEH inhibitor (sEHI) N-[1-(oxopropyl)-4-piperidinyl]-N’-[4-(trifluoromethoxy) phenyl)-urea (TPPU) and exogenous 14,15-EET increased HFS-LTP, which could be blocked by an N-methyl-D-aspartate (NMDA) receptor subunit NR2B antagonist. TPPU- or 14,15-EET-facilitated FSK-mediated LTP can be potentiated by an A1 adenosine receptor antagonist and a phosphodiesterase inhibitor, but is prevented by a cAMP-dependent protein kinase (PKA) inhibitor. sEHI and 14,15-EET upregulated the activation of extracellular signal-regulated kinases (ERKs) and Ca2+/calmodulin- (CaM-) dependent protein kinase II (CaMKII). Phosphorylation of synaptic receptors NR2B and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluR1 was increased by TPPU and 14,15-EET administration. These results indicated that EETs increased NMDAR- and FSK-mediated synaptic potentiation via the AC-cAMP-PKA signaling cascade and upregulated the ERKs and CaMKII, resulting in increased phosphorylation of NR2B and GluR1 in the hippocampus.
format Article
id doaj-art-ef3d991706ae413fa6ff50506c182736
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-ef3d991706ae413fa6ff50506c1827362025-02-03T06:06:09ZengWileyNeural Plasticity2090-59041687-54432017-01-01201710.1155/2017/34678053467805Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the HippocampusHan-Fang Wu0Yi-Ju Chen1Su-Zhen Wu2Chi-Wei Lee3I-Tuan Chen4Yi-Chao Lee5Chi-Chen Huang6Chung-Hsi Hsing7Chih-Wei Tang8Hui-Ching Lin9Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Anesthesiology, Chi-Mei Medical Center, Tainan, TaiwanDepartment and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, TaiwanGraduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanGraduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanDepartment of Anesthesiology, Chi-Mei Medical Center, Tainan, TaiwanDepartment of Neurology, Far Eastern Memorial Hospital, New Taipei City, TaiwanDepartment and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, TaiwanEpoxyeicosatrienoic acids (EETs) are derived from arachidonic acid and metabolized by soluble epoxide hydrolase (sEH). The role of EETs in synaptic function in the central nervous system is still largely unknown. We found that pharmacological inhibition of sEH to stabilize endogenous EETs and exogenous 14,15-EET significantly increased the field excitatory postsynaptic potential (fEPSP) response in the CA1 area of the hippocampus, while additionally enhancing high-frequency stimulation- (HFS-) induced long-term potentiation (LTP) and forskolin- (FSK-) induced LTP. sEH inhibitor (sEHI) N-[1-(oxopropyl)-4-piperidinyl]-N’-[4-(trifluoromethoxy) phenyl)-urea (TPPU) and exogenous 14,15-EET increased HFS-LTP, which could be blocked by an N-methyl-D-aspartate (NMDA) receptor subunit NR2B antagonist. TPPU- or 14,15-EET-facilitated FSK-mediated LTP can be potentiated by an A1 adenosine receptor antagonist and a phosphodiesterase inhibitor, but is prevented by a cAMP-dependent protein kinase (PKA) inhibitor. sEHI and 14,15-EET upregulated the activation of extracellular signal-regulated kinases (ERKs) and Ca2+/calmodulin- (CaM-) dependent protein kinase II (CaMKII). Phosphorylation of synaptic receptors NR2B and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluR1 was increased by TPPU and 14,15-EET administration. These results indicated that EETs increased NMDAR- and FSK-mediated synaptic potentiation via the AC-cAMP-PKA signaling cascade and upregulated the ERKs and CaMKII, resulting in increased phosphorylation of NR2B and GluR1 in the hippocampus.http://dx.doi.org/10.1155/2017/3467805
spellingShingle Han-Fang Wu
Yi-Ju Chen
Su-Zhen Wu
Chi-Wei Lee
I-Tuan Chen
Yi-Chao Lee
Chi-Chen Huang
Chung-Hsi Hsing
Chih-Wei Tang
Hui-Ching Lin
Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus
Neural Plasticity
title Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus
title_full Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus
title_fullStr Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus
title_full_unstemmed Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus
title_short Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus
title_sort soluble epoxide hydrolase inhibitor and 14 15 epoxyeicosatrienoic acid facilitated long term potentiation through camp and camkii in the hippocampus
url http://dx.doi.org/10.1155/2017/3467805
work_keys_str_mv AT hanfangwu solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT yijuchen solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT suzhenwu solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT chiweilee solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT ituanchen solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT yichaolee solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT chichenhuang solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT chunghsihsing solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT chihweitang solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus
AT huichinglin solubleepoxidehydrolaseinhibitorand1415epoxyeicosatrienoicacidfacilitatedlongtermpotentiationthroughcampandcamkiiinthehippocampus